- Topic
- Product safety
- Regulator
- FDA
- Published
- 9 October 2026
- For
- Imports
- Where it applies
- United States
From the notice
The Food and Drug Administration (FDA) is classifying the hematopoietic cell enrichment kit into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the hematopoietic cell enrichment kit. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of the safety and effectiveness of the device. We believeThe full text is at the source
Olive tells you which of these hit your products.
Olive reads every change like these against your own products, codes and trade lanes, whether you import, export or both, and drafts the update to your compliance program for your approval. Nothing changes without you.
Olivra lists official notices for information only. It is not legal advice, and Olive is not a lawyer or a licensed customs broker. The official text at the source is what counts.
More from FDA
- Safety
Amneal Pharmaceuticals of New York, LLC; Withdrawal of Approval of Abbreviated New Drug
FDAUnited StatesImports - Safety
Challenges and Solutions in Lot-Level Food Traceability; Public Meeting
FDAUnited StatesImports - Safety
Determination of Regulatory Review Period for Purposes of Patent Extension; MONOFERRIC
FDAUnited StatesImports - Safety
Determination That LASIX (Furosemide) Oral Solution, 10 Milligrams/Milliliter, Was Not Withdrawn
FDAUnited StatesImports